Objective: Survivors of critical illness are frequently left with longlasting disability. The association between delirium and disability in critically ill patients has not been described. We hypothesized that the duration of delirium in the ICU would be associated with subsequent disability and worse physical health status following a critical illness. Design: Prospective cohort study nested within a randomized controlled trial of a paired sedation and ventilator weaning strategy. Setting: A single-center tertiary-care hospital. Patients: One hundred twenty-six survivors of a critical illness.
Objective: Survivors of critical illness are frequently left with longlasting disability. The association between delirium and disability in critically ill patients has not been described. We hypothesized that the duration of delirium in the ICU would be associated with subsequent disability and worse physical health status following a critical illness. Design: Prospective cohort study nested within a randomized controlled trial of a paired sedation and ventilator weaning strategy. Setting: A single-center tertiary-care hospital. Patients: One hundred twenty-six survivors of a critical illness. Measurements and Main Results: Confusion Assessment Method for the ICU, Katz naire were used. Associations between delirium duration and outcomes were determined via proportional odds logistic regression with generalized estimating equations (for Katz activities of daily living and Functional Activities Questionnaire scores) or via generalized least squares regression (for Medical Outcomes Study 36-item Short Form General Health Survey Physical Components Score and Awareness Questionnaire scores). Excluding patients who died prior to follow-up but including those who withdrew or were lost to follow-up, we assessed 80 of 99 patients (81%) at 3 months and 63 of 87 patients (72%) at 12 months. After adjusting for covariates, delirium duration was associated with worse activities of daily living scores (p = 0.002) over the course of the 12-month study period but was not associated with worse instrumental activities of daily living scores (p = 0.15) or worse Medical Outcomes Study 36-item Short Form General Health Survey Physical Components Score (p = 0.58). Duration of delirium was also associated with lower Awareness Questionnaire Motor/Sensory Factors scores (p 0.02). Conclusion: In the setting of critical illness, longer delirium duration is independently associated with increased odds of disability in activities of daily living and worse motor-sensory function in the following year. These data point to a need for further study into the determinants of functional outcomes in ICU survivors. (Crit Care Med 2014; 42:369-377) Key Words: activities of daily living; delirium; intensive care unit T he number of patients who survive critical illness each year is increasing (1) (2) (3) . Many of these survivors have physical disabilities after their critical illness and treatment in the ICU despite being functionally independent prior to their acute critical illness (4, 5) . These disabilities can result in inability to carry out basic activities of daily living (ADLs) that are essential to independent living (e.g., bathing, dressing, toileting, transferring, continence, and feeding) and instrumental activities of daily living (IADLs) that facilitate independent living (e.g., handing financial matters, assembling business affairs or papers, shopping alone for groceries, playing a game of skill or working on a hobby, making a cup of coffee, preparing a balanced meal, keeping track of current events, understanding a book or TV show, remembering appointments, and traveling outside of one's neighborhood) (4-6). Thus, newly acquired disability among the large and growing number of patients leaving the hospital after critical illness represents an important healthcare and societal problem in years to come.
Knowledge about risk factors for disability after critical illness is an important but unmet need. In non-critical illness hospitalizations, delirium is associated with disability in the months and years following the index illness (7) (8) (9) (10) (11) . Delirium in the ICU occurs in 60-80% of mechanically ventilated patients and 20-40% of nonventilated patients (12) (13) (14) (15) (16) (17) . The longer a patient is delirious in the ICU, the more likely he or she is to develop cognitive impairment or die (17) (18) (19) . The duration of delirium in the ICU has never been examined as a risk factor for long-term disability. Older patients are particularly susceptible to the development of delirium and therefore may be placed at a disproportional risk to suffer the long-term consequences of this syndrome. Given the high prevalence of delirium in the ICU and the association between delirium and newly acquired disabilities in other populations, we hypothesized that the duration of delirium in the ICU is associated with subsequent functional disability and poorer physical health status in the year following critical illness. To test this hypothesis, we conducted a prospective cohort study to determine whether the duration of delirium in the ICU is associated with functional outcomes up to 1 year later in adult medical ICU patients.
MATERIALS AND METHODS

Study Design and Participants
We nested this single-center prospective cohort study within the Awakening and Breathing Controlled (ABC) trial (Clini-calTrials.gov NCT 00097630), a multicenter randomized trial that compared a paired sedation and ventilator weaning protocol with usual care (20) . Due to limited personnel and funding, we conducted this long-term outcomes study at a single large, private, tertiary care center, Saint Thomas Hospital in Nashville, TN. Between October 2003 and March 2006, study personnel reviewed the medical ICU census daily to identify patients 18 years old or older who were mechanically ventilated for more than 12 hours. Patients meeting these inclusion criteria were excluded from the parent study if they were mechanically ventilated for more than 2 weeks prior to screening, admitted following cardiac arrest, not committed to receiving aggressive therapy and/or moribund, unable to live independently at baseline due to profound neurologic deficits, or enrolled in another trial that prohibited co-enrollment. Patients who survived until hospital discharge, did not have severe neurologic deficits (e.g., severe dementia or stroke), and had not undergone cardiac or neurologic surgery were included in this follow-up study.
Surrogate decision makers provided written informed consent at the time of enrollment since patients were typically unable to consent while mechanically ventilated; the participants themselves consented prior to hospital discharge if they were competent to do so. The Vanderbilt Coordinating Center (Nashville, TN) supervised and conducted the trial, and the institutional review boards at Saint Thomas Hospital and Vanderbilt University (Nashville, TN) approved the study protocol.
Exposure
The primary exposure, chosen a priori, was duration of delirium occurring in the ICU during the 28-day study period. We chose duration of ICU delirium as the exposure, rather than the dichotomous "ever/never" presence of delirium, because we expected that a patient who had short-lived delirium (e.g., 1 day of delirium) would more closely resemble the patient who had no delirium than a patient who was delirious for days. Furthermore, there is a growing body of literature suggesting that delirium duration (i.e., the "dose" of delirium), rather than simply its presence or absence, is associated with multiple longterm outcomes, including mortality and long-term cognitive impairment (18, 19, 21) . Finally, dichotomization of a continuous variable results in a significant loss of power, increases the risk of type I error, and may conceal nonlinearity in the relation between the variable and the outcome (22) .
Each day, trained study personnel (either research nurses or physicians) assessed patients who were in the ICU and not comatose for delirium using the Confusion Assessment Method for the ICU (CAM-ICU), a brief well-validated screening instrument for detection of delirium in critically ill patients (12, 13) . The Richmond Agitation-Sedation Scale (RASS) (23, 24) was used to assess level of consciousness, and coma was defined as a RASS of -5 (no response to verbal or physical stimulation) or -4 (response to physical stimulation without response to verbal stimulation). Delirium duration was defined as the number of days a patient was CAM-ICU positive in the ICU during the 28-day study period. Since we did not assess for delirium following discharge from the ICU, we considered each non-ICU day, up to the end of the 28-day observation period, as a day free of delirium.
Outcomes and Covariates
At 3 and 12 months following hospital discharge, a clinical neuropsychologist (J.C.J.)-who was blinded to and thus unaware of any details concerning the course of each patient's critical illness (including duration of delirium)-assessed survivors inperson using a battery of functional and physical health status measures. Follow-up testing typically occurred in the patients' homes, with a few patients returning to the study center for follow-up. Since no single tool provides complete information regarding a patient's overall functional status, we utilized four validated questionnaires to assess multiple aspects of physical functioning. Specifically, we used the Katz ADL (25) and the Functional Activities Questionnaire (FAQ) (26) to assess ADLs and IADL, respectively. To assess physical health status, we used the Medical Outcomes Study 36-item Short Form General Health Survey (SF-36) and calculated the physical component score (PCS) using the standard approach (27) . Finally, we used the Motor/Sensory Factors component of the Awareness Questionnaire (AQ) (28) to assess the patient's perceptions of change in motor-sensory function following critical illness.
For each of the six ADLs assessed, we assigned patients reporting independence a score of 0, those reporting partial dependence a score of 1, and those reporting complete dependence a score of 2. Thus, a patient who was completely dependent (i.e., disabled) in all ADLs would receive a score of 12, whereas a patient who was completely independent would receive a score of 0.
For IADL outcomes, patients were given 0 points if they reported no difficulty completing an IADL, 1 point if they reported difficulty doing the IADL but could do it without assistance, 2 points if they reported requiring assistance with the IADL, and 3 points if the patient reported complete dependency in the IADL. Therefore, a patient with complete dependence (i.e., disabled) in all 10 IADLs would receive a score of 30 and a patient with complete IADL independence would have a score of 0.
The SF-36 PCS comprises 21 questions from the SF-36 subdomains of physical function, role physical, bodily pain, and general health (29) . Each question is scored from 0 to 100 with lower scores indicating poor physical health status. Individual question scores are combined into subdomain scores, which are used to derive the PCS score.
The AQ measures self-ratings of functional abilities (28) . The Motor/Sensory Factors component comprises four questions regarding arm and leg movement, eyesight, coordination, and hearing. Patients are asked to compare current function to preillness function. Scoring is done on a 5-point scale from 1 to 5, where 1 indicates "much worse" function and 5 indicates "much better" function (i.e., a higher score indicates better function). Thus, the possible scores range from 4 (much worse in all four areas) to 20 (much better in all four areas).
To adjust for potential confounding, we selected covariates a priori based on clinical and biologic plausibility. These covariates included age, severity of illness at the time of enrollment in the parent study, severe sepsis, duration of coma in the ICU during the 28-day study period, and baseline ADL and IADL scores. Severity of illness at ICU admission was calculated using the acute physiology score portion of the Acute Physiologic and Chronic Health Evaluation (APACHE) II score (30) . Severe sepsis at ICU admission was identified using the treating physicians' diagnosis and confirmed using international consensus definitions (31) . Baseline (i.e., precritical illness) ADL scores were determined using surrogate responses to the Katz ADL (32), and baseline IADL scores were determined using surrogate responses to the FAQ (26) . The surrogate who completed these questionnaires was a person who knew the patient well enough to answer detailed questions about the patient's functional abilities during the time shortly (e.g., 1-2 mo) before the onset of their critical illness.
Both the Katz ADL and the FAQ have been shown to be valid and demonstrate good agreement when completed by the patient (as was done during the follow-up phase of the current study) or by their surrogate (as was done when assessment of baseline functioning was performed) (26, 33) .
Statistical Analysis
Baseline demographics and clinical characteristics were examined using median and interquartile ranges for continuous variables and proportions for categorical variables. We analyzed patients from this trial population as a single cohort rather than according to intervention group assignment since previous analyses did not find differences in functional outcomes between patients randomized to the intervention protocol and those randomized to usual care (34) .
We used proportional odds logistic regression with generalized estimating equations for scores on the Katz ADL and the FAQ, evaluated as continuous outcome measures, to determine whether duration of delirium was independently associated with subsequent disability in ADL and IADL functioning during the first year following critical illness (35) . To assess the relationship between delirium duration and physical health status and between delirium duration and subsequent perception of motor-sensory function, we used generalized least squares regression that contained SF-36 PCS scores and AQ scores as continuous outcome measures. We chose these statistical models based on the distribution of the outcomes (e.g., ADL and IADL outcomes were highly skewed and clustered around 0), the ability to assess outcomes as continuous measures (which increases power to detect associations between the exposure and outcome of interest, detect nonlinearity in the exposureoutcome relationship, and reduces residual confounding), and their superior ability to account for missing covariate data.
Age, APACHE II acute physiology score, severe sepsis, and duration of coma were included in all regression models, regardless of statistical significance. In addition, we included baseline Katz ADL and FAQ scores as covariates in the respective Katz ADL and FAQ score models, to adjust for pre-illness functional abilities.
Length of time a patient spends in the ICU is likely associated with long-term functional outcomes and may therefore confound the relationships being studied, but because delirium duration and ICU length of stay were very highly correlated (Spearman's ρ = 0.77), we could not adjust directly for ICU length of stay. Instead, we accounted for the total length of ICU stay by including duration of delirium, duration of coma, and duration of "normal" mental status (three mutually exclusive periods of time, which together account for the entire length of stay) in our models.
Finally, we performed a sensitivity analysis, adding ABC trial treatment group assignment and body mass index (BMI) at ICU admission as covariates into our a priori model.
Nonlinearity of the associations between the primary exposure variable and delirium duration, as well as the covariates age and coma duration, was assessed by inclusion of restricted cubic splines in the regression models; these associations were assumed to be nonlinear unless the p value of the nonlinear term was greater than 0.20, in which case the nonlinear term was excluded from the model. We used R (version 2.8.1 patched, http://www.r-project.org) for all statistical analyses.
RESULTS
Of the 187 patients who were enrolled in the parent study at Saint Thomas Hospital, 54 died during the hospitalization, and seven were excluded from this long-term study (Fig. 1) . Thus, 126 patients survived and were eligible for inclusion in this long-term prospective cohort. Follow-up was achieved in 80 of the 99 patients (81%) alive at 3-month follow-up and in 62 of the 87 patients (71%) alive at 12-month follow-up (52 patients completed all four questionnaires at both time points).
Baseline demographics and clinical characteristics of the study population are shown in Table 1 . The majority of patients were 61 years old or older, and more than a quarter were 71 years old or older. Baseline disability in ADLs (defined as an ADL score ≥ 1) was present in 25% of patients and disability in IADLs (defined as an FAQ score ≥ 9) was present in 21% of patients. Patients had a high severity of illness at ICU admission and nearly half were admitted with sepsis and/or acute respiratory distress syndrome (ARDS). Patients were mechanically ventilated for a median (interquartile range) of 5.0 days (1.9-9.1 d).
Delirium was highly prevalent, with delirium developing in 84% of patients while in the ICU. Delirium persisted for at least 2 days in half the patients, and one quarter of patients were delirious for 5 days or more. Patients who died following discharge, withdrew following discharge, or were lost to follow-up did not differ significantly from those patients who followed up with respect to delirium duration (2 d [1-6 d] vs 2 d [1-5 d], respectively).
At the 3-and 12-month follow-up assessments, the median (interquartile range) Katz ADL scores were 0 (0-1) and 0 (0-1), respectively. Disability in ADLs was present in one in three patients at both 3-and 12-month follow-ups ( Table  2 ). The primary ADL disabilities were bathing, dressing, and continence, and each were present in one in five patients at 3 months and in 13%, 8%, and 21%, respectively, at 12 months. Scores on the FAQ (IADL function) were 3 (0-6) at 3-month follow-up and 1 (0-5) at 12-month follow-up. Disability in IADLs was present in 17% of those assessed at 3 months and 5% of those assessed at 12 months (Table 2 ). Physical health status was poor for nearly all patients throughout follow-up, with SF-36 PCS of 27 (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) at 3 months and 28 (21-37) at 12 months. Finally, Motor-Sensory Factors scores were 11 (9-12) and 11 (9-12) at 3-and 12-month follow-up, respectively, with over 60% of patients reporting worse motor-sensory function at both follow-up time points (Table 2) .
After adjusting for age, baseline ADL function, severity of illness at admission, sepsis at admission, and duration of coma, a longer duration of delirium in the ICU was associated with an increased probability of a higher ADL score over the course of the 12-month follow-up period ( Table 3 ) (p = 0.002). Figure 2A models the nonlinear association between duration of delirium in the ICU and probability of a higher Katz ADL score during longterm follow-up (i.e., patients with the longest duration of delirium in the ICU were most likely to report worse ADL function).
Duration of ICU delirium was not associated with increased odds of a higher IADL score over the follow-up period (p = 0.15) ( Table 3) . Similarly, delirium duration was not associated with lower scores on the PCS component of the SF-36 (p = 0.58) (Table 3 ). After adjusting for covariates, duration of ICU delirium was associated with lower AQ Motor/ Sensory Factors scores over the course of the follow-up period (p = 0.02) ( Table 3 ). Figure 2B illustrates the association between duration of delirium in the ICU and lower scores on the Motor/Sensory Factors component of the AQ. Thus, the longer a patient was delirious the more likely he or she was to perceive his or her motor-sensory function as worse during follow-up compared with his or her preillness condition.
After adjusting for the duration of days in the ICU with "normal" mental status, the nonlinear association between the duration of delirium and the odds of a higher ADL score at follow-up remained significant (p = 0.007) as did the association between delirium duration and lower scores on the Motor/ Sensory Factors component of the AQ (-0.5 [95% CI, -1.0 to -0.1]; p = 0.028).
Similarly, the sensitivity analysis including ABC trial treatment group assignment and BMI as covariates to the original regression models yielded similar results to those in the original models.
DISCUSSION
The main findings of this study are that the duration of delirium in the ICU was independently associated with disability in ADLs in the year following critical illness after adjusting for covariates, including baseline ADL function, and the longer a patient was delirious in the ICU, the more likely he or she was to report worse motor-sensory function during followup compared with his or her preillness state. Delirium duration was not independently associated with IADL disability or worse physical health status. Nevertheless, these results indicate that the long-term deleterious effects associated with delirium extend beyond cognition and mortality to functional outcomes as well. They highlight the need for effective delirium prevention and treatment strategies, which may reduce functional disabilities among survivors of critical illness and add to the growing literature regarding poor functional outcomes among survivors of critical illness (4, 5) .
Although in noncritically ill and postoperative populations, delirium has been associated with ADL disability during both intermediate (e.g., 3-6 mo) and long-term (e.g., 12 mo) periods of follow-up (8-11, 36, 37) , to our knowledge, no previous study has shown an association between delirium duration and ADL disability in survivors of critical illness. Marcantonio et al (8) found that elderly patients with persistent delirium 1 month following hip fracture surgery had worse ADL function than those who had delirium that resolved before hospital discharge; both of these groups had worse ADL function than patients who were never delirious. Similarly, Quinlan and Rudolph (11) found that functional decline was more prevalent in a population of elderly noncardiac surgery patients whose delirium persisted for 3 or more days compared with those who were delirious for 1-2 days or were never delirious. Despite these findings in non-ICU populations, it cannot be assumed that the adverse outcomes associated with delirium outside the ICU are applicable to those patients with delirium in the ICU. In this case, our results are indeed consistent with findings in other noncritically ill populations and support our hypothesis that duration of ICU delirium is associated with post-ICU disability. The mechanisms underlying the association between delirium duration and ADL disability are not yet known. One potential mechanism relates to the fact that most delirious ICU patients have hypoactive delirium (i.e., with reduced physical activity) (38, 39) . As a result of reduced spontaneous physical activity, patients may be subject to disuse muscle atrophy, predisposing them to ICU-acquired weakness (ICU-AW) (40) (41) (42) (43) . Even in the absence of overt ICU-AW, restricted physical activity is associated with subsequent physical disability (44) . Thus, immobility associated with hypoactive delirium may lead to functional disability in the months and years following critical illness. This hypothesis is in need of testing in future trials.
Interestingly an intervention designed to reduce immobility and prevent ICU-AW through the use of early physical and occupational therapy (PT/OT) in mechanically ventilated patients (e.g., beginning within 1-2 days of initiation of mechanical ventilation) was associated with a reduction in delirium duration compared with those who began PT/OT later (7 days after initiation of mechanical ventilation) (45) . Furthermore, patients in the early PT/OT group were more likely to return to their baseline functional status (e.g., free of ADL and IADL disability). Thus, early physical and occupational rehabilitation is associated with improvements in both delirium duration and functional outcomes. The directionality of these effects remains unknown, but these data do suggest a brain-body connection. Our patients did not specifically receive early PT/OT, a practice that has grown in scope since these data were collected, and thus, our findings are in need of corroboration in light of this changing ICU clinical practice.
The brain-body connection may represent different manifestations of a common underlying mechanism. Inflammation, which is often present in critical illness syndromes such as severe sepsis and ARDS, may link delirium and muscle wasting associated with critical illness (46, 47) . Additionally, the geriatric syndromes of delirium and physical frailty have been hypothesized to be linked via inflammation, atherosclerosis, and genetics and/or nutritional deficiencies (48) .
Two in three patients reported worse motor/sensory functioning during the follow-up period, and worse motor/sensory functioning was associated with delirium duration. These results highlight a link between delirium and lesser grades of impaired physical functioning not rising to the level of disability. This finding indicates that the effects on physical functioning are far reaching. Nonetheless, the transition from Factors score from the Awareness Questionnaire) for outcome after adjusting for covariates over the course of the 12-mo follow-up period from the 25th percentile to the 75th percentile. c Because the association is nonlinear, the magnitude of the association cannot be summarized using a single odds ratio; therefore, the association is graphed in Figure 2A . independence to disability in ADLs stands as a clinically significant transition in other populations and is associated with an increased risk of institutionalization, greater healthcare expenditures, increased hospitalizations, and death among the elderly (49) (50) (51) (52) . Whether survivors of critical illness are subject to these same poor outcomes following new onset disability is unknown, and long-term outcomes studies involving disabled survivors of critical illness are needed.
Duration of delirium in the ICU has been previously associated with numerous other short-term adverse outcomes, including prolonged mechanical ventilation (21) and prolonged hospitalization (53) , as well as long-term adverse outcomes, such as persistent cognitive impairment (17) , and increased mortality up to 1 year after critical illness (18, 19) . Our findings add to the growing body of evidence regarding the long-term outcomes associated with delirium duration, and for clinicians, the findings highlight the importance of monitoring and treating delirium in the critically ill.
As noted above, duration of ICU delirium was not associated with IADL disability during follow-up, nor was it associated with physical components of health status. Because our trial was powered for ventilator-free days, the primary outcome in the parent (ABC) trial, we were likely underpowered to detect significant outcomes with respect to these follow-up outcomes. Alternatively, the mechanisms linking delirium and ADL function may not be relevant to IADL function, since some of the skills and abilities important to the former are different from those required for the latter. Additionally, IADL disability could have been present early in the post-ICU course but resolved by the time of follow-up assessment as evidenced by the smaller proportion of patients reporting IADL disability at 12-month follow-up compared with those reporting disability at 3-month follow-up. A similar finding was reported by Rudolph et al (7) in a cohort of postoperative cardiac surgery patients where worse IADL function was present at 1-month follow-up, but the association was no longer present at 12 months.
Our study has both strengths and weaknesses. Strengths include its prospective cohort design, daily delirium assessment with a validated delirium assessment tool administered by trained research personnel, blinding of the outcomes assessor as to delirium status in the ICU, high follow-up rate, adjustment for important confounders including ICU length of stay, and the use of multiple wellvalidated tools to assess outcomes. Weaknesses include its size, the possibility of residual confounding which affects all observational trials, adjustment for all potentially important confounders (such organ failures or sepsis developing during the ICU stay and doses of sedatives and analgesics received), single-center nature-which may limit generalizability-use of self-reported measures of functioning rather than objective performance based measures of physical capabilities, and lack of pre-ICU administration of questionnaires necessitating reliance on surrogate assessments of baseline functional status, the latter being limitations of nearly all ICU followup studies, since critical illness is unplanned and emergent.
We were able, though, to determine the association between delirium and functional disability by estimating precritical illness ADL and IADL function via surrogate-completed Katz ADL and FAQ questionnaires; both provide good agreement between patients and surrogate ratings (26, 33) . We may have underestimated the true amount of disability among survivors of a critical illness who experience delirium since we inquired about disability at the specific follow-up time points only, rather than inquiring about disability "at any time" since the prior assessment, a method which more accurately ascertains Figure 2 . A, Association between duration of delirium in the ICU and probability of a higher Katz activities of daily living (ADL) score (indicating disability) over the course of the year following hospitalization for critical illness, after adjusting for age, severity of illness at admission, sepsis at admission, duration of coma, and baseline ADL function (solid line). As the number of days of ICU delirium increases, so does the probability of developing worse ADL function (p = 0.002). Dashed lines indicate 95% CIs. Interpretive example: on average, with all other covariates being equal, as the number of days of delirium increase from 6 days (75th percentile of delirium duration) to 12 days (90th percentile of delirium duration), the odds of being disabled in ADLs during the year following a critical illness increase by 3.47 (95% CI, 1.93-6.24). b, Association between duration of delirium in the ICU and score on the Motor/Sensory Factor of the Awareness Questionnaire over the course of the year following hospitalization for critical illness, after adjusting for age, severity of illness at admission, sepsis at admission, and duration of coma (solid line). As the number of days of ICU delirium increased, the Awareness Questionnaire Motor/Sensory Factors score decreased (p = 0.02), indicating greater perceived impairment in limb movement, eyesight, coordination, and hearing compared with preillness state. Possible scores on this measure range from 4 to 20, with lower scores indicating worse perceived functioning compared with preillness functioning. Dashed lines represent 95% CIs. the occurrence of disability (54) . We did not assess agreement between surrogate rating and patient ratings of functional status in our study. Nevertheless, studies in non-ICU populations comparing patient and surrogate ADL and IADL assessment report overall good agreement, and when disagreement was present between the two, patients tended to report better functioning than surrogates (33, (55) (56) (57) (58) . This tendency, if present in our cohort, would bias the results toward the null hypothesis since we used a surrogate rater at baseline and compared that rating to a patient rating at follow-up. This investigation was limited to data collected at enrollment and during the first year of follow-up after the ICU stay; thus, we did not measure trajectory of preillness functional status. Therefore, it may be the case that patients already on a downward functional status trajectory were at risk for prolonged delirium. Future studies adjusting for not only baseline functional status but the trajectory of preillness functional status are needed to address this possible source of confounding.
Days of Delirium
Finally, because duration of delirium is associated with higher mortality in the months following a critical illness, unmeasured variables among those who survived and completed follow-up may bias our results (survival bias).
CONCLUSIONS
In summary, this study found that duration of delirium in the ICU was independently associated with increased odds of newly acquired disability, as measured by ADL function and awareness of change in physical function, during the first year following critical illness. These results add to the growing body of literature regarding adverse outcomes associated with delirium and highlight that poor outcomes associated with delirium extend beyond delirium's association with impaired cognition and death. Further study into the underlying mechanism(s) linking delirium and long-term disability as well as whether measures aimed at preventing and treating delirium may also prevent poor functional outcomes in survivors of critical illness is needed. These findings further the understanding of the long-term consequences of delirium and elevate the importance of monitoring for delirium for ICU clinicians.
